Efficiency of Ferrotherapy When Using Different Groups of Iron Drugs in Patients with Helicobacter Pylori

Authors

  • Yuldashova Rano Urinbayevna Bukhara state medical institute

Keywords:

Iron-deficiency anemia, Helicobacter pylori, iron drugs, eradication therapy

Abstract

To date, a number of scientific studies are being conducted in the world devoted to the study of various variants of the manifestation of helicobacteriosis. Special attention should be paid to studies on the pathogenesis of iron drugs (ID) in helicobacteriosis and the role of eradication therapy in improving the effectiveness of iron therapy. Despite the fact that there are results of numerous studies confirming the role of HP in the development of ID, there are still unresolved issues related to determining the exact indications for specific therapy aimed at eradicating this infection in cases where patients with clinical and laboratory signs of ID do not have obvious symptoms damage to the gastric mucosa.

Downloads

Published

2022-08-22

How to Cite

Urinbayevna, Y. R. . (2022). Efficiency of Ferrotherapy When Using Different Groups of Iron Drugs in Patients with Helicobacter Pylori. International Journal of Innovative Analyses and Emerging Technology, 2(8), 31–36. Retrieved from https://oajournals.net/index.php/ijiaet/article/view/1549

Issue

Section

Articles